6-K/A

AMENDMENT NO. 1 TO FORM 6-K

Company: XTL BIOPHARMACEUTICALS LTD
Filed: March 21, 2024
Period of Report: March 21, 2024
Accession Number: 0001213900-24-024838

View Document ↗ View on SEC.gov ↗